Peroxide of magnesium
Magnesium peroxide, inorganic chemical compound
HSN 2816 10 20 (Peroxide of magnesium) is subject to Central Board of Indirect Taxes and Customs (CBIC) mandatory Chapter 28 qualifier requirements under CBIC Circular 23/2023-Cus dated 30-09-2023, operative from 15 October 2023. Where the consignment is classified as a drug, additional CDSCO-aligned documentation — including a registration certificate, import licence, certificate of analysis, and batch release certificate — must be uploaded in e-Sanchit before out-of-charge.
- Certificate of analysis from supplier
- Registration certificate from CDSCO
- Import licence for drugs from CDSCO
- 1Include all mandatory additional qualifiers in the import declaration for Chapter 28 commodities as stipulated in paragraphs 4.1 and 4.2 of CBIC Circular 23/2023-Cus. This requirement is operative with effect from 15 October 2023 and non-compliance will result in the bill of entry being held for correction before out-of-charge.CBIC Circular 23/2023-Cus dated 30-09-2023, paragraphs 4.1 and 4.2
- 2Where the peroxide of magnesium is imported as or classified as a drug, upload in e-Sanchit the certificate of analysis (document code 0010dc), batch release certificate (0030dc), label of consignment (0110dc), registration certificate for drugs (101dc1), and import licence for drugs (9111dc) before filing the bill of entry. The proper officer verifies each document code prior to granting out-of-charge.CBIC Circular 23/2023-Cus dated 30-09-2023; e-Sanchit document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc
The single most common error on this tariff line is failing to distinguish between a general industrial-chemical import and a drug-classified import: importers shipping magnesium peroxide for pharmaceutical or therapeutic use without uploading the five drug-specific document codes (0010dc, 0030dc, 0110dc, 101dc1, 9111dc) face consignment detention at the port of entry pending e-Sanchit compliance. Additionally, omission of the Chapter 28 mandatory qualifiers in the import declaration — even where the drug-document overlay does not apply — independently triggers a hold under CBIC Circular 23/2023-Cus, attracting demurrage and ground rent until the declaration is rectified.